Pharma Equity Group
0.156
DKK
-0.64 %
PEG
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
13 following
-0.64%
-5.74%
-23.9%
-35.8%
-23.9%
-63.72%
-67.77%
-50.48%
-84.63%
-99.4%
pharmaequitygroup.com/investors
Pharma Equity Group develops new medicines for the local treatment of serious and life-threatening inflammatory diseases for which there is currently no adequate treatment. The company uses repositioning of existing drugs and brings drug candidates to a clinical phase III stage, after which it is handed over to a strategic partner who will complete the development of the products and bring them to market, either independently or in collaboration with the company.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Copenhagen
PEG
Daily low / high price
0.156 / 0.162
DKK
Market cap
191.5M DKK
Turnover
2.1K DKK
Volume
13K
Analyst
Claus Thestrup
CEO, Sweden
ShowingAll content types
Pharma Equity Group: Opdatering fra interview med CEO Thomas K. Selsø
Pharma Equity Group – Gennemgang af 3. kvartal og styrkelsen af selskabets kapitalstruktur
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Konsolideret delårsrapport 1. januar – 30. september 2024
Consolidated Interim report 1 January – 30 September 2024
Dagens aktienyheder 29/10: NTG | Nordic Transport Group A/S, Green Hydrogen Systems, BioPorto A/S og Pharma Equity Group A/S
Pharma Equity Group (One-pager): Capital position strenghtened
Dagens aktienyheder 24/10: Skjern Bank, MapsPeople, BioPorto, Pharma Equity Group og Audientes
Pharma Equity Group’s datterselskab (Reponex Pharmaceuticals A/S) har opnået patentbeskyttelse i Japan på behandling af colorectal cancer med RNX-051.
Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051.
Dagens aktienyheder 14/10: Pharma Equity Group, Boozt og banker
Major shareholder announcement - Pharma Equity Group A/S
Storaktionærmeddelelse - Pharma Equity Group A/S
Ledende medarbejderes transaktioner
Managers’ transactions
Dagens aktienyheder 11/10: BioPorto, Pharma Equity Group, GreenMobility og SaaS sektoren
Pharma Equity Group offentliggør succesfuld gennemførsel af rettet emission
Pharma Equity Group announces successful completion of directed issue of new shares
Dagens aktienyheder 7/10/25: Pharma Equity Group A/S, Ascelia Pharma AB og GomSpace